Latest American Society of Clinical Oncology Stories
Guardant Health to Launch Cancer Management Tools For Analytics and Visualization of Dynamic Tumor Genomics REDWOOD CITY, Calif., May 27, 2015 /PRNewswire/ -- Guardant Health® today announced
WESTON, Fla., May 18, 2015 /PRNewswire/ -- Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications
AUSTIN, Texas, May 14, 2015 /PRNewswire/ -- Vermillion, Inc.
AURORA, Colorado, May 14, 2015 /PRNewswire/ -- Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer
Clinical data from a Phase 1 investigator-sponsored study to be presented for MM-398 in high-grade glioma CAMBRIDGE, Mass., May 14, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.
SAN DIEGO, May 13, 2015 /PRNewswire/ -- GenomeDx Biosciences today announced that multiple studies featuring clinical data from the company's Decipher platform will be presented at the 2015
- Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503,
REDWOOD CITY, Calif., May 13, 2015 /PRNewswire/ -- ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced that clinical data from a Phase 1 clinical trial of AM0010, a PEGylated
Patients Include Uninsured, Underinsured and Those Who Cannot Afford Full Course of Treatment, Co-Pays FORT MYERS, Fla., May 4, 2015 /PRNewswire/ -- 21(st) Century Oncology, the world's
-VAL-083 Clinical Presentation on Monday, June 1, 2015, from 1:15-4:45 p.m.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.